FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program
The agency is committed to providing a public update on the new vision at the end of January 2023 and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Dec 22
The agency is committed to providing a public update on the new vision at the end of January 2023 and…
07 Dec 22
Ivonescimab, which is designed to block PD-1, has breakthrough therapy designation status in China for three cancer indications
06 Dec 22
The EC approval of Mycapssa is backed by efficacy and safety data from three phase 3 studies in…
05 Dec 22
The deal combines Immunocore's TCR bispecific engineering, development, and marketing capabilities with Gadeta's gamma delta target and TCR…
02 Dec 22
Multiply Labs has installed a new robotic system at WuXi STA’s facility in Wuxi city to produce solid…
01 Dec 22
The Global Heart Hub aims to implement change in the way unhealthy cholesterol levels are prevented and managed at local…
01 Dec 22
The approval is based on the findings from a clinical programme including data from the late-stage PUNCH CD3…
29 Nov 22
The clinical-stage company took an immunoproteomics approach to extract and identify naturally presented MHC Class I-restricted peptides on…
25 Nov 22
The MAA submission to the MHRA for NPC and ESCC indications is based on findings from the JUPITER-02…
24 Nov 22
The XeriJect formulation technology will be used for producing an ultra-concentrated, ready-to-use, subcutaneous injection of the ophthalmic drug